These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 7539903)

  • 21. Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma.
    Saito H; Tsujitani S; Katano K; Ikeguchi M; Maeta M; Kaibara N
    Cancer; 1998 Sep; 83(6):1094-101. PubMed ID: 9740073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD44v6 expression in non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis.
    Ristamäki R; Joensuu H; Söderström KO; Jalkanen S
    J Pathol; 1995 Jul; 176(3):259-67. PubMed ID: 7545748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expressions of E-cadherin and exon v6-containing isoforms of CD44 and their prognostic values in human transitional cell carcinoma.
    Hong RL; Pu YS; Hsieh TS; Chu JS; Lee WJ
    J Urol; 1995 Jun; 153(6):2025-8. PubMed ID: 7538603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD44V6 in gastric carcinoma: a marker of tumor progression.
    Xin Y; Grace A; Gallagher MM; Curran BT; Leader MB; Kay EW
    Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):138-42. PubMed ID: 11396631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
    Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
    Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
    Tran TA; Kallakury BV; Sheehan CE; Ross JS
    Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer.
    Yamamichi K; Uehara Y; Kitamura N; Nakane Y; Hioki K
    Int J Cancer; 1998 Jun; 79(3):256-62. PubMed ID: 9645347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of MUC1, CD44v6, nm23 in gastric carcinomas and regional lymph node tissues and their association with invasion, metastasis, and prognosis of the tumor].
    Li Y; Zhang JH; Kuang G; Yang JQ; Zhao Q; Wang XL; Jiao ZK; Zhang ZD; Wang LL
    Ai Zheng; 2003 Sep; 22(9):985-9. PubMed ID: 12969535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferential expression of the cell adhesion molecule CD44 in papillary thyroid carcinoma.
    Figge J; del Rosario AD; Gerasimov G; Dedov I; Bronstein M; Troshina K; Alexandrova G; Kallakury BV; Bui HX; Bratslavsky G
    Exp Mol Pathol; 1994 Dec; 61(3):203-11. PubMed ID: 7541370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation.
    Yanagisawa N; Mikami T; Mitomi H; Saegusa M; Koike M; Okayasu I
    Cancer; 2001 Jan; 91(2):408-16. PubMed ID: 11180088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of expression of CD44 isoforms and E-cadherin with differentiation in human urothelial cell lines and transitional cell carcinoma.
    Hong RL; Pu YS; Chu JS; Lee WJ; Chen YC; Wu CW
    Cancer Lett; 1995 Feb; 89(1):81-7. PubMed ID: 7533658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical localization of CD44 variants 5 and 6 in human gastric mucosa and gastric cancer.
    Mirecka J; Marx D; Schauer A
    Anticancer Res; 1995; 15(4):1459-65. PubMed ID: 7544568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of CD44v6 in adenocarcinoma of the pancreas: an immunohistochemical study.
    Castellà EM; Ariza A; Ojanguren I; Mate JL; Roca X; Fernández-Vasalo A; Navas-Palacios JJ
    Virchows Arch; 1996 Nov; 429(4-5):191-5. PubMed ID: 8972753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
    Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
    Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical analyses of CD44 variant isoforms in invasive micropapillary carcinoma of the breast: comparison with a concurrent conventional invasive carcinoma of no special type component.
    Umeda T; Ishida M; Murata S; Mori T; Kawai Y; Itoi N; Tomida K; Tanaka A; Sakai S; Kitamura M; Kubota Y; Kushima R; Tani M
    Breast Cancer; 2016 Nov; 23(6):869-875. PubMed ID: 26494575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of CD44 variants expression in colorectal cancer.
    Li XD; Ji M; Wu J; Jiang JT; Wu CP
    Tumori; 2013; 99(1):88-92. PubMed ID: 23549006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients.
    Li Z; Chen K; Jiang P; Zhang X; Li X; Li Z
    Diagn Pathol; 2014 Apr; 9():79. PubMed ID: 24708709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance.
    Ghaffarzadehgan K; Jafarzadeh M; Raziee HR; Sima HR; Esmaili-Shandiz E; Hosseinnezhad H; Taghizadeh-Kermani A; Moaven O; Bahrani M
    World J Gastroenterol; 2008 Nov; 14(41):6376-81. PubMed ID: 19009655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low serum levels of soluble CD44 variant 6 are significantly associated with poor prognosis in patients with pancreatic carcinoma.
    Gansauge F; Gansauge S; Rau B; Scheiblich A; Poch B; Schoenberg MH; Beger HG
    Cancer; 1997 Nov; 80(9):1733-9. PubMed ID: 9351541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of epidermal growth factor receptor and CD44 splicing variants sharing exons 6 and 9 on gastric and esophageal carcinomas: a two-color flow-cytometric analysis.
    Koyama S; Maruyama T; Adachi S
    J Cancer Res Clin Oncol; 1999; 125(1):47-54. PubMed ID: 10037277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.